Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerebrovascular Reaction to Nitrous Oxide in Treatment-Resistant Depression (PROTO-BRAIN)
2019-002769-37Phase 2Completed
- Sponsor
- CHRU Tours
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of nitrous oxide in treatment-resistant depression (TRD) (3 arms), sponsored by CHRU Tours. Primary endpoint: Cerebral pulsatility indices by TPI ultrasound. Started Jul 2019; status: completed.
02
Drugs
nitrous oxide
03
Conditions
treatment-resistant depression (TRD)
Beyond the preview
Go deeper on 2019-002769-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002769-37.